> but because the drug was out of patent, pharmaceutical companies had not interest in slowing down the vaccines. This is a thing that often gets claimed, but

> but because the drug was out of patent, pharmaceutical companies had not interest in slowing down the vaccines. This is a thing that often gets claimed, but there's a special three-year "New Clinical Investigation Exclusivity" that's available. (https://www.fda.gov/media/135234/download https://www.fda.gov/media/135234/download p15)